高级检索
当前位置: 首页 > 详情页

BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Guangdong Med Coll, Inst Clin, Lab Med, Dept Clin Immunol, Dongguan 523808, Peoples R China [2]Dongguan Hosp Prophylaxis & Treatment Chron Dis, Dongguan 523008, Peoples R China [3]Guangdong Prov Key Lab Med Mol Diagnost, Dongguan 523808, Peoples R China [4]Guangdong Med Coll, Affiliated Hosp, Dept Clin Lab Med, Zhanjiang 524000, Guangdong, Peoples R China [5]Huazhong Univ Sci & Technol, Tongji Hosp, Ctr Biomed Res, Wuhan 430030, Peoples R China [6]Univ Illinois, Coll Med, Ctr Primate Biomed Res, Dept Microbiol & Immunol, Chicago, IL USA
出处:
ISSN:

关键词: Human active pulmonary tuberculosis B and T lymphocyte attenuator memory T cells alpha beta T cells

摘要:
Despite past extensive studies, the role of B and T lymphocyte attenuator (BTLA) in alpha beta T cells in patients with active pulmonary tuberculosis (ATB) remains poorly understood. Here we demonstrate that BTLA expression on alpha beta T cells is decreased in patients with M. tuberculosis (Mtb) infection. Particularly, BTLA expression levels are likely critical for alpha beta T cells to manifest and maintain an active central memory phenotype with high capacity for secretion of IFN-gamma and perforin, which are important for immune memory against TB infection. BTLA(high) alpha beta T cells also exhibited higher capacity in response to Mtb peptide stimulation. In contrast to the role of BTLA played for negative regulation of immune responses, our data in the current studies suggest that BTLA expression on alpha beta T cells is likely associated with protective immune memory against Mtb infection in the setting of patients with active pulmonary tuberculosis. This previous unappreciated role for BTLA may have implications for prevention and treatment of patients with Mtb infection.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2012]版:
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Guangdong Med Coll, Inst Clin, Lab Med, Dept Clin Immunol, Dongguan 523808, Peoples R China [3]Guangdong Prov Key Lab Med Mol Diagnost, Dongguan 523808, Peoples R China
通讯作者:
通讯机构: [1]Guangdong Med Coll, Inst Clin, Lab Med, Dept Clin Immunol, Dongguan 523808, Peoples R China [3]Guangdong Prov Key Lab Med Mol Diagnost, Dongguan 523808, Peoples R China [*1]Guangdong Med Coll, Inst Clin, Lab Med, Dept Clin Immunol, 1 Xincheng Rd, Dongguan 523808, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)